mutations, chromosomal aberrations and azoospermic factor (AZF) microdeletions, are believed to have an important role [1] [2] [3] [4] . However, few genetic defects have been identified in humans so far. In recent years, studies from a series of infertile mouse models revealed hundreds of candidate genes that are associated with male infertility, especially idiopathic spermatogenic impairment [1] [2] [3] . Now, it is known that not only gene mutations but also some gene polymorphisms may affect male infertility [5] .
Spermatogenesis is a complex process that requires strict gene expression, in which protein phosphorylation
Introduction
Greater than 10% of couples are unable to achieve pregnancy, about half of which are due to male infertility, in which genetic defects, including gene npg is a critical event in protein modification and signal conduction. Through phosphorylation of proteins, the testis-specific serine/threonine kinase (TSSK) family, which is expressed abundantly in the testis, is deeply involved in sperm differentiation, capacitation and fertilization [6] [7] [8] [9] [10] [11] . Up to now, five members of this family have been identified, including TSSK1, TSSK2, TSSK3, TSSK4 and TSSK6. The expression of TSSK1 and TSSK2 is limited to meiotic and postmeiotic spermatogenic cells, respectively [7, 12] . TSSK3 presents exclusively in and may function in Leydig cells [8, 13] . TSSK4 phosphorylates the cAMP responsive element binding protein, which is important for germ cell differentiation [10, 14] . Our previous study proposed that some single-nucleotide polymorphisms (SNPs) of TSSK4 may contribute to the susceptibility to idiopathic spermatogenic impairment [15] .
TSSK6, also named small serine/threonine kinase, is expressed in elongating spermatids, and its coding gene, TSSK6, is mapped to 19p13.11, with only one exon encoding 273 amino acids [9, 16] . A further study proposed that TSSK6 can phosphorylate histones H1, H2A, H2AX and H3, and can associate with heat shock protein HSP90 and HSC70 [16] . Both histones and HSPs perform significant functions during spermatogenesis. More importantly, male mice with a targeted deletion of Tssk6 are infertile, showing considerable reduction in sperm counts, impaired DNA condensation, abnormal morphology and impaired spermatozoa motility [16] . The above evidence strongly suggested that TSSK6 is essential for spermatogenesis and male fertility. However, whether TSSK6 is also associated with human male infertility still needs to be investigated. In the present study, we carried out mutation screening of the entire coding region, the 5' untranslated region (UTR) and 3' UTR of the TSSK6 gene, in 519 patients with azoospermia or severe oligozoospermia and 359 controls, and compared the results between the two groups.
Materials and methods

Study participants
This study was approved by the Institutional Ethics Review Board of West China Hospital, Sichuan University, China. A total of 878 unrelated Chinese Han people were recruited from West China Hospital, Sichuan University. The 519 enrolled infertile patients, aged 25-40 years, included 273 with azoospermia and 246 with severe oligozoospermia (sperm concentration < 5 × 10 6 sperm mL -1 ). All of them underwent at least two semen analyses according to the World Health Organization guidelines (1999) [17] . In addition, these patients had been examined to exclude obstruction of the vas deferens, cryptorchidism, varicocele, chromosomal abnormalities and microdeletions of the AZF region on the Y chromosome according to karyotyping and STS analysis in the AZF region [18] . The control group consisted of 359 fertile men with normospermia aged 25-50 years. All participants gave their informed consent.
Polymerase chain reaction amplification
Genomic DNA was extracted from peripheral blood lymphocytes by standard phenol-chloroform methods [19] . Based on the mRNA sequence (GenBank No. NM_032037) and the genomic sequence, three pairs of primers were designed using PRIMER PREMIER 5.0 (Premier Biosoft International, Palo Alto, CA, USA) to amplify the entire coding region, 5' UTR and 3' UTR (Table 1) . Polymerase chain reactions (PCRs) were carried out npg in a total volume of 50 mL containing 0.2 mg genomic DNA, 10 pmol of each primer, 10 pmol of dNTP and two units of Taq polymerase. The PCR cycling protocols included predenaturation at 94ºC for 5 min, followed by 35 amplification cycles of denaturation at 94ºC for 30 s, annealing at 59ºC and 63.4ºC for 30 s, extension at 72ºC for 1 min, and a final extension at 72ºC for 10 min. To genotype c.822+126T>G/C, primer mismatch PCRs were used to amplify a 302-bp fragment at an annealing temperature of 59ºC and to create a new site recognized by restriction endonucleases AvaII, BanI and KpnI (F: 5'-CTGCCG CGTGCTGCTGCACATGCGCTTTTTCGG-3' and R: 5'-GCCAGGTGCGAGGAACAGCGAGT-3'). Amplicons were resolved by 1.5% agarose gel electrophoresis to confirm the specific PCR products.
Denaturing high-performance liquid chromatography analysis and DNA sequencing
Screening of TSSK6 variations was carried out using denaturing high-performance liquid chromatography (DHPLC) on an automated WAVE system (Transgenomic, Omaha, Nebraska). WAVEMAKER 4.1 software was used to determine the optimal melting temperature for the tested fragments. Before DHPLC, the PCR products were denatured at 94ºC for 5 min and cooled at room temperature for 45 min. Then, 6 mL of each product was injected into a highthroughput DNASep column and eluted with a linear acetonitrile gradient of 2% per minute at a flow rate of 0.9 mL min -1 . The elution profiles of the heterozygous fragments were represented as aberrantly shaped peaks, whereas the homozygous fragments were represented as single peaks. After DHPLC, the heterozygous fragments were reamplified and purified with a QIAquick PCR Purification Kit (Qiagen, Hilden, Germany) and sent for direct sequencing in both directions using an ABI 3100 DNA Sequencer (Applied Biosystems, Foster City, CA, USA).
Genotyping and statistical analysis
Genotyping for all identified variations, including SNPs, was carried out by PCR restriction fragment length polymorphism analysis (AvaII, BanI, KpnI). After endonuclease digestion, the products were electrophoresed on a 3% agarose gel and observed with a Gel Doc1000 system (Figure 1) .
Hardy-Weinberg equilibrium (HWE) was tested using the HWE program. The differences in genotypic and allelic frequencies between the infertile patients and controls were assessed by χ 2 test using SPSS 11.0 software (SPSS Inc, Chicago, IL, USA).
Results
After screening of the entire coding region, the 5'UTR and 3'UTR of the TSSK6 gene, in 519 infertile men with oligo-/azoospermia and 359 controls, we failed to find any SNPs registered in the NCBI dbSNP database, but we identified a novel singlenucleotide variation in both groups, which is a triallelic polymorphism located in the 3'UTR ( Figure 2 ). According to the nomenclature recommendations of sequence variations by the Human Genome Variation Society (http://www.hgvs.org/mutnomen) [20] , this polymorphism was named c.822+126T>G/C.
The genotype distributions c.822+126T>G/C did not deviate from HWE (P > 0.05) in patients and controls (data not shown). The genotype CC was detected only in one control, whereas the genotype CG was found in six fertile men and in one azoospermic patient, respectively. No genotype GG was detected in either group. The distributions of the genotype and allele frequencies of c.822+126T>G/C in the cases and controls are presented in Table 2 .
Bonferroni's corrections were made for multiple comparisons of genotype and allele frequencies between the different groups [21] [22] [23] . The comparison results are summarized in Table 2 . After applying Bonferroni's correction, the difference with the corrected P < 0.0083 npg was considered statistically significant. As shown in Table 2 , among possible six genotypes of c.822+126T>G/C, four genotypes (TT, TC, TG and CG) with frequencies of over 1% were detected in controls. The frequency of genotype TT increased dramatically in patients compared with that in controls (86.32% vs. 73.26%, P < 0.001), whereas the frequency of genotype TG was significantly lower in patients than in controls (0.96% vs. 6.13%, P < 0.001). No obvious difference in the frequencies of genotypes TC and CG between patients and controls was observed. Both allele C and G frequencies of c.822+126T>G/C were significantly higher in controls than in patients (allele C: 10.45% vs. 6.36%, P = 0.002; allele G: 3.90% vs. 0.58%, P < 0.001).
After the infertile patients were classified into azoospermic and oligospermic sub-groups, the coincident frequency differences of both alleles and genotypes between either of the sub-groups and the controls still remained, except that the frequency of allele C had no statistical difference between the azoospermic patients and controls (Table 2) . Moreover, we did not observe any differences in either alleles or genotypes between azoospermic and oligospermic patients (data not shown).
Discussion
Until now, the aetiology and pathogenesis of idiopathic male infertility were still not fully understood. Although a number of candidate genes related to male infertility were reported, most of them have not been tested and confirmed in humans. Gene mutation npg screening in infertile patients with spermatogenic impairment is currently the most effective way to explore the possible genetic causes of infertility. Our group aimed to investigate the roles of the TSSK family in idiopathic human male infertility. We had performed mutation screening of TSSK4 [15] and T S S K 2 (Communicated) in Chinese infertile patients.
It has been shown that TSSK6 can participate in the regulation of gene expression during spermatogenesis in several ways, including phosphorylating histones, H1, H2A, H2AX and H3. However, in our previous study in infertile men, we did not find any mutations or genetic risk factors of H2AX [24] . On the other hand, male mice with null Tssk6 were infertile. Therefore, we hypothesized that the TSSK6 may associate with human male infertility and carried out gene mutation screening in patients with azoospermia or oligospermia. After examining 878 subjects, only a novel triple polymorphism, c.822+126T>G/C, located in the 3'UTR was detected in both groups, and it was confirmed by DNA sequencing. Further association study disclosed that the frequencies of allele T and genotype TT were significantly higher in infertile patients than in controls, and that the differences still remained between either azoospermic or oligospermic patients and controls. These results suggest that allele T of c.822+126T>G/C may be a genetic risk factor for male infertility (OR: 2.247). However, its frequency in the control group was still high (85.65%), suggesting that the effect of allele T per se on reproductive fitness may be mild. Compared with individuals carrying allele T, carriers with allele G seem to have a lower risk for infertility, as the frequencies of allele G and genotype TG decreased significantly in azoospermic and/or oligospermic patients (OR: 0.143 and 0.149). For allele C, after the infertile patients were divided into azoospermic and oligospermic groups, a statistical difference remained only between oligospermic patients and controls (6.36% vs. 10.45%), indicating that allele C may have a protective effect against oligospermia (OR: 0.517).
Although our study failed to find gene mutations, it was based on a large sample size and suggested that the novel triple polymorphism c.822+126T>G/C of the TSSK6 gene may be a genetic susceptibility factor for the development of spermatogenic impairment in humans. Recently, many reports have shown that the SNP in UTRs could have an impact on mRNA stability, translation efficiency and gene expression [25] [26] [27] [28] . After searching the microRNA database, no target sequence was found. Whether this polymorphism influences mRNA stability and gene function warrants further investigation. Moreover, considering that the infertile TSSK6 knockout mouse mainly presented s p e r m n u m b e r r e d u c t i o n a n d a b n o r m a l s p e r m morphology and mobility, studying the mutation of the TSSK6 gene in patients with oligospermia or teratozoospermia is an optional method to illuminate its possible contribution to spermatogenic impairment in the future.
